CAS
SRNE

Coppell Advisory Solutions’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Coppell Advisory Solutions’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$89 – 1928
2023
Q3 		$89 Buy
+100
New +$89 ﹤0.01% 1148
2023
Q1 		– Sell
-100
Closed -$89 – 1202
2022
Q4 		$89 Buy
+100
New +$133 ﹤0.01% 1150

Other funds holding SRNE

LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return
SW
SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return